Trailing Twelve Months Sales Growth: IGC Pharma, Inc. (IGC)

Graphic logo of IGC Pharma (IGC)

Strict government control over transportation guarantees the reliability of supply chains. The annual revenue growth rate (rolling period) on the GURU.Markets chart demonstrates stability, where -6.50 describes the current status of the metric. The financial potential of IGC Pharma, Inc. (IGC) is based on a closed patent portfolio for Alzheimer's disease therapy and the active expansion of its cannabinoid drug line to improve patient quality of life.

IGC - India Globalization Capital Sales Growth YoY (TTM) over the range 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for IGC Pharma, Inc. (IGC)

- company stock exchange capitalization indicators:
Summary company analytics:IGC (India Globalization Capital)
Brand item of IGC Pharma Inc

IGC Pharma, Inc. (IGC) focuses on high-risk Alzheimer's disease research, where revenue depends on development stages. This indicator captures the daily price action of revenue changes over a rolling year relative to the previous period. The metric identifies the acceleration or deceleration of operating flows, signaling a shift in the fundamental trend. For a biotech company, this serves as a marker for the transition from laboratories to patent commercialization. By analyzing the year-over-year sales growth percentage for TTM, an investor determines the business scaling stage.